Literature DB >> 14557062

Egr-1 target genes in human endothelial cells identified by microarray analysis.

Mingui Fu1, Xiaojun Zhu, Jifeng Zhang, Jian Liang, Yiming Lin, Luning Zhao, Markus U Ehrengruber, Yuqing E Chen.   

Abstract

Early growth response factor 1 (Egr-1) is a key transcriptional factor to mediate gene expression after vascular injury. To better understand the role of Egr-1 in vasculature, we globally profiled Egr-1 target genes in human endothelial cells using adenoviral gene transfer and Affymetrix oligonucleotide-based microarray technology. More than 300 genes regulated by >/=3-fold with Egr-1 overexpression were identified and, partially, confirmed by Northern and Western blotting, including genes for transcriptional regulators, signaling proteins, cell cycle regulatory proteins, growth factors, and cytokines. Among them, thymus-expressed chemokine (TECK) and IP-30 were dramatically induced by Egr-1, but TNFalpha-related apoptosis inducing ligand (TRAIL) was significantly repressed by Egr-1, suggesting that Egr-1 is a key mediator of inflammation and apoptosis in vascular cells. These data provide novel Egr-1 target genes and contribute to the understanding of the role of Egr-1 in vasculature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557062     DOI: 10.1016/s0378-1119(03)00730-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  55 in total

Review 1.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.

Authors:  Joshua Abd Alla; Andreas Langer; Sherif S Elzahwy; Gökhan Arman-Kalcek; Thomas Streichert; Ursula Quitterer
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

3.  Signal transducer and activator of transcription 1 negatively regulates constitutive gamma interferon-inducible lysosomal thiol reductase expression.

Authors:  Priya Srinivasan; Maja Maric
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

4.  Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.

Authors:  Ivana Fantozzi; Wei Huang; Jifeng Zhang; Shen Zhang; Oleksandr Platoshyn; Carmelle V Remillard; Patricia A Thistlethwaite; Jason X-J Yuan
Journal:  Exp Lung Res       Date:  2005-10       Impact factor: 2.459

5.  Wound site neutrophil transcriptome in response to psychological stress in young men.

Authors:  Sashwati Roy; Savita Khanna; Pier-En Yeh; Cameron Rink; William B Malarkey; Janice Kiecolt-Glaser; Bryon Laskowski; Ronald Glaser; Chandan K Sen
Journal:  Gene Expr       Date:  2005

6.  PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.

Authors:  Wendy Roeb; Antonia Boyer; Webster K Cavenee; Karen C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

7.  Osmoadaptation of Mammalian cells - an orchestrated network of protective genes.

Authors:  Küper Christoph; Franz-X Beck; Wolfgang Neuhofer
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

8.  Nutritional factors and progenitor cell differentiation.

Authors:  A Dembinska-Kie C; A Polus; J Grzybowska; B Kiec-Wilk; A Balwierz; J Keijer; G Schmitz
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

Review 9.  Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.

Authors:  Nor Saadah M Azahri; Mary M Kavurma
Journal:  Cell Mol Life Sci       Date:  2013-01-18       Impact factor: 9.261

10.  Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Authors:  Meenakshi Upreti; Azemat Jamshidi-Parsian; Scott Apana; Marc Berridge; Daniel A Fologea; Nathan A Koonce; Ralph L Henry; Robert J Griffin
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.